市场调查报告书
商品编码
1494672
疝气修补市场:按产品类型、手术、适应症和最终用户划分 - 全球预测 2024-2030Hernia Repair Market by Product Type (Hernia Mesh, Mesh Fixator, Suture), Surgery (Laparoscopic Surgery, Open Surgery, Robotic Surgery), Indication, End-user - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年疝气修补市场规模为45.6亿美元,预计2024年将达47.8亿美元,2030年将达65.2亿美元,复合年增长率为5.23%。
疝气修补是指一种旨在纠正器官从周围肌肉或组织壁撕裂处突出时发生的疝气的外科手术。当器官透过周围肌肉或组织壁的撕裂突出时,就会发生疝气。这种情况通常可以透过开放性手术或微创手术来矫正。促进疝气修復手术扩大的关键因素包括对该疾病的认知增加、手术技术的进步以及肥胖症(疝气的主要危险因子)盛行率的增加。然而,疝气修补手术并非没有风险,例如感染、復发,以及某些情况下的慢性术后疼痛。解决这些问题需要继续研究更先进的手术技术、材料和术后护理通讯协定,以减轻这些风险并促进患者康復。网片材料和技术的创新,例如生物可吸收网片和机器人辅助手术的开发,有望改善手术结果并减少併发症,从而促进疝气修復手术在全球的普及。
主要市场统计 | |
---|---|
基准年[2023] | 45.6亿美元 |
预测年份 [2024] | 47.8亿美元 |
预测年份 [2030] | 65.2亿美元 |
复合年增长率(%) | 5.23% |
区域洞察
在美国,特别是美国,由于强大的医疗基础设施和大量的研发投资,对技术先进的疝气修復产品(例如复合网片和生物同种异体移植物)的需求很高。该地区的主要企业受益于强大的分销网络和全面的产品系列。由于人们对先进疝气修復方案的认识不断提高、医疗成本不断增加以及医疗保健设施不断改善,亚太地区的疝气修復术正在迅速增长。然而,该地区的市场更加分散,全球和本地参与者都存在,导致产品范围多样化和具有竞争力的定价策略。 EMEA(欧洲、中东和非洲)地区面临着多种场景,西欧已开发市场注重创新和质量,而中东和非洲市场对价格敏感并逐渐采用新技术。区域公司正在扩大在欧洲、中东和非洲地区的业务,提供先进且经济高效的解决方案组合,以满足多样化的市场需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在疝气修补市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对疝气修復市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在疝气修復市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Hernia Repair Market size was estimated at USD 4.56 billion in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 5.23% to reach USD 6.52 billion by 2030.
Hernia repair refers to a surgical procedure aimed at correcting hernias, which occur when an organ protrudes through a tear in the surrounding muscle or tissue wall. This condition is often corrected through either open surgery or minimally invasive surgeries. The major factors contributing to the expansion of hernia repair procedures include the increasing awareness of the condition, advancements in surgical technologies, and the rising prevalence of obesity, which is a major risk factor for hernias. However, hernia repair procedures are not without their risks, including the risk of infection, recurrence, and, in some cases, chronic pain post-surgery. Addressing these issues requires ongoing research into more advanced surgical techniques, materials, and post-operative care protocols aimed at reducing these risks and enhancing patient recovery. Innovations in mesh materials and techniques, such as the development of bio-absorbable meshes and robot-assisted surgeries, promise to improve outcomes and reduce complications, thus driving further adoption of hernia repair procedures worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.56 billion |
Estimated Year [2024] | USD 4.78 billion |
Forecast Year [2030] | USD 6.52 billion |
CAGR (%) | 5.23% |
Regional Insights
In the Americas, especially the United States, there is a high demand for technologically advanced hernia repair products such as composite meshes and biologic allografts, driven by a strong healthcare infrastructure and substantial investment in R&D. Major companies in this region benefit from robust distribution networks and comprehensive product portfolios. The APAC region is witnessing rapid growth in hernia repair, fueled by increasing awareness about advanced hernia repair options, rising healthcare expenditure, and improving healthcare facilities. However, the market here is more fragmented, with both global players and local companies, leading to a diverse product range and competitive pricing strategies. The EMEA region presents a diverse scenario with advanced markets in Western Europe focusing on innovation and quality, while markets in the Middle East and Africa are more price-sensitive and gradually adopting newer technologies. Regional companies are expanding in the EMEA region, offering a mix of advanced and cost-effective solutions to cater to varied market demands.
Market Insights
The market dynamics represent an ever-changing landscape of the Hernia Repair Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hernia Repair Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hernia Repair Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for USD 540 Million
STERIS PLC entered into a definitive agreement to acquire surgical and laparoscopic instrumentation and sterilization container assets from Becton, Dickinson, and Company (BD) for a total consideration of USD 540 million. This strategic acquisition encompasses the well-regarded V. Mueller, Snowden-Pencer, and Genesis brands, reinforcing STERIS's position in providing premium surgical instruments and sterilization solutions to healthcare customers. [Published On: 2023-06-20]
US Regulatory Approval Granted for LiquiBandFix8A
Advanced Medical Solutions Group PLC, a significant player in tissue-healing technologies, announces its recent accomplishment of receiving Pre-Market Approval (PMA) from the U.S. Food and Drug Administration (FDA) for LiquiBandFix8. This approval, a pivotal moment for the company, came ahead of the anticipated schedule, just seven months post-submission, signifying a major success for our debut PMA application. This rapid authorization speaks to our application's exceptional quality and highlights the significant advantages LiquiBandFix8 offers patients undergoing hernia surgeries. [Published On: 2023-06-05]
Tissium Raises Euro 50 Million (USD 54 Million) in Series D Funding to Finance its Commercial Launch and Platform Extension
Tissium, an innovative player in biomorphic programmable polymers for tissue reconstruction, secured a euro 50 million (USD 50 million) investment in its Series D financing round. This fundraising achievement aligns with a series of pivotal accomplishments for the company, particularly the progression of its study of COAPTIUM Connect for nerve repair in Australia, alongside various regulatory endeavors. The newly secured funds are instrumental in advancing TISSIUM's strategic milestones, explicitly supporting the commercial launch of its inaugural products in nerve and hernia repair. [Published On: 2023-05-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hernia Repair Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Hernia Repair Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Medical Solutions Limited, Aran Biomedical, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company,, BioCer Entwicklungs-GmbH, Dolphin Sutures, DynaMesh, Herniamesh Srl, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lotus Surgicals Pvt. Ltd., Medtronic PLC, Olimp - Surgical sutures, Orion Sutures India Pvt. Ltd., SERAG-WIESSNER GmbH & Co. KG, Shandong Haidike Medical Products Co., Ltd., Spire Healthcare Group PLC, SUGII SURGICAL INDIA PRIVATE LIMITED, Surgical Sutures Private Limited, TELA Bio, Inc, Unisur Lifecare Private Limited, W. L. Gore & Associates, Inc., and Zhejiang Geyi Medical Instrument Co., Ltd..
Market Segmentation & Coverage